Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-12-23
2009-08-04
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S262000
Reexamination Certificate
active
07569571
ABSTRACT:
Provided are bicyclic heterocycle-based p38 kinase, including p38α and p38β kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amelioration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.
REFERENCES:
patent: 6005109 (1999-12-01), Faraci et al.
patent: WO03/097062 (2003-11-01), None
patent: WO03/099820 (2003-12-01), None
STN search downloaded Feb. 16, 2008.
Dong Qing
Lan Jiong
Lang Hengyuan
Wang Jianqiang
Coleman Brenda L
Milstead Mark W.
Moore Susanna
Novartis AG
LandOfFree
Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4076142